Chronic hypertension, diabetes and blood clots are more likely in otherwise healthy women who experienced complications due to hypertension such as preeclampsia in their first pregnancies, according to Yale School of Medicine researchers working in collaboration with the University of Copenhagen, Denmark.
The findings are presented in an abstract at the Society for Maternal Fetal Medicine […]

A study conducted by Universit?© de Montr?©al researchers on downstream and upstream water from the Montreal wastewater treatment plant has revealed the presence of chemotherapy products and certain hypertension and cholesterol medications.
Bezafibrate (cholesterol reducing medication), enalapril (hypertension medication), methotrexate and cyclophosphamide

Addrenex Pharmaceuticals
announced that the U.S. Food and Drug Administration has approved its
Investigational New Drug Application (IND) for ADX415, a novel hypertension
drug. With the approval, Addrenex has launched a phase 2 clinical trial to
study ADX415 as a targeted therapy for hypertension.
The phase 2 trial is a multicenter, […]

Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, have announced that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes. The study, which

A Lifeclinic LC300 automated blood pressure monitor was recently featured on the new CBS daytime talk show, The Doctors. The series airs each weekday, delivering up-to-the-minute information from a panel of four practicing medical professionals.
During the October 30th episode, a segment entitled "Heart of the Matter", Dr. Travis Stork discussed the anatomy of the human […]

Rasilez HCT® (aliskiren and hydrochlorothiazide) received a positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) recommending marketing authorization as a new treatment for high blood pressure. Rasilez HCT is a single-pill combination of two high blood pressure medicines - first-in-class direct renin inhibitor Rasilez®[1] (aliskiren)

United Therapeutics Corporation (Nasdaq: UTHR) announced the results of the FREEDOM-C trial of oral treprostinil, a sustained-release formulation of treprostinil, in pulmonary arterial hypertension (PAH). Preliminary analysis demonstrates that the trial did not achieve statistical significance for the primary endpoint, six minute walk (6MW) distance at Week 16.
The FREEDOM-C trial was a randomized, double-blind, […]

According to a report published in the August 27 issue of JAMA,
a drug that lowers uric acid levels, allopurinol, also seems to lower
blood pressure in adolescents with newly diagnosed hypertension (high
blood pressure).
Hyperuricemia - a condition characterized by higher than normal blood
levels of uric acid

Bayer Schering Pharma was granted European marketing authorization for its new antihypertensive fixed dose combination drug PritorPlus® 80/25 and Kinzalkomb® 80/25 (80 mg telmisartan/25 mg hydrochlorothiazide) by the European Commission. The new formulation will be launched in Germany later this month, to be followed soon by selected

Several factors, such as older age and high weight gain, are known risk factors for pre-eclampsia and other pregnancy-related blood pressure disorders. Now a new report suggests that social factors - including living in a rural county - may also increase the risk of pre-eclampsia and pregnancy-induced hypertension (PIH), according to research presented at the […]

The drug allopurinol, which lowers uric acid levels, appears to reduce blood pressure in adolescents with newly diagnosed hypertension, according to a preliminary report in the August 27 issue of JAMA.
Hypertension is commonly associated with hyperuricemia (elevated blood level of uric acid, a by-product of normal chemical

The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT® (valsartan and hydrochlorothiazide) and Exforge® (amlodipine and valsartan), as initial or ‘first-line’ therapies in patients likely to need multiple drugs to achieve their blood pressure goals.
The FDA approval of

Latest News For Mental Health
Mind Comments On Government ‘Fit Note’ Plans, UK
26 Nov 2008
Guidance Issued On Improving Patient Safety In Mental Health And Learning Disability Services, UK
26 Nov 2008
‘Mind’ Comments On Government ‘Fit Note’ Plans, UK
26 Nov 2008
generic cipro

Metabolex, Inc., a
biopharmaceutical company focused on the discovery and development of
proprietary new medicines for the treatment of metabolic diseases,
announced positive results from a Phase 1a clinical trial of MBX-2982. A
summary of the results was presented at the World Congress on Controversies
to Consensus […]

New clinical data presented show first-in-class direct renin inhibitor Rasilez® (aliskiren), known as Tekturna® in the US, provides significantly greater blood pressure reductions in patients with high blood pressure aged 65 and over, compared to the angiotensin-converting enzyme (ACE) inhibitor ramipril[1].
Results from the

Anyone with a nose knows the rotten-egg odor of hydrogen sulfide, a gas generated by bacteria living in the human colon. Now an international team of scientists has discovered that cells inside the blood vessels of mice - as well as in people, no doubt - naturally make the gassy stuff, and that it controls […]

UroToday.com - A study by Dr. Bonita Falkner, et al., examined the presence and persistence of the prehypertension and hypertension classifications as well as the progression of prehypertension to hypertension in pediatrics. They analyzed the data from the National Childhood Blood Pressure database to

Racial disparity in the control of hypertension contributes to the deaths of almost 8,000 black men and women in the United States annually, according to a first-of-its-kind study published today in the Annals of Family Medicine by University of Rochester Medical Center researchers.
The researchers concluded that the deaths could

NicOx
Generic ultram pills no prescription S.A. (Euronext Paris: COX) announced that a new analysis of the data
from the 104 Ambulatory Blood Pressure Monitoring (ABPM) study for
naproxcinod was presented yesterday at the American Heart Association
Scientific Sessions

NicOx
S.A. (Euronext Paris: COX) announced positive top-line results from a
118 patient Ambulatory Blood Pressure Monitoring (ABPM) trial (the 111
study), which compared the 24-hour blood pressure profile of escalating
doses of naproxcinod and naproxen in osteoarthritis (OA) patients with
controlled hypertension.

Social environment may play a greater role in the disparity between the numbers of African Americans living with hypertension compared to non-Hispanic whites with the disease. A study by researchers at the Johns Hopkins Bloomberg School of Public Health found that the disparity was substantially reduced when comparing groups of African Americans and non-Hispanic whites […]

Latest News For Depression
Generic lasix pills no prescription How Can Physicians Recognize Depression At Early Stages? A New Method Is Suggested
03 Oct 2008
Patients Experience Significant Long-Term Benefits After Seeking Help For

Buy generic lasix NicOx S.A. (NYSE Euronext Paris: COX) announced that the third pivotal phase 3 study for naproxcinod in patients with OA of the hip showed a highly statistically significant result

Latest News For Ear, Nose and Throat
Keeping Your Sinuses Clear, Seven Tips From Harvard Men’s Health Watch
25 Nov 2008
Presence Of Gum Disease May Help Dentists And Physicians Identify Those At Increased Risk For Cardiovascular Disease
25 Nov 2008
Laparoscopic Heller Myotomy Esophagea A Minimally Invasive Surgery To Treat Achalasia
21 Nov 2008
Generic

Two new national health studies show that more adults in the US are living with hypertension than ever before; while this is bad news in that the
proportion of the population with high blood pressure has gone up, it is also good news in that more people are living with rather than dying from high blood
pressure. […]